Study on the effect of burdock grain nutrition powder on diabetic patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400091629

Enrollment

Unknown

Registered

2024-10-31

Start date

2021-05-02

Completion date

Unknown

Last updated

2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Treatment group:In addition to health education, the subjects were given 2 bags of burdock grain nutrition powder a day, and 1 bag with boiled water or milk in the morning and evening respectively. Ea

Control group:Regular dietary guidance

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The diagnostic criteria for type 2 diabetes stipulated by WHO in 1999 was used as the diagnostic criteria for type 2 diabetes in this study. Fasting blood glucose >= 7mmol/L (126mg/dl) or 2 hours post-meal blood glucose >= 11.1mmol/L (200mg/dl), or random blood glucose >= 11.1mmol/L.

Exclusion criteria

Exclusion criteria: 1. Patients with type I diabetes 2.Persons under 18 years of age or over 65 years of age, pregnant or lactating women, who are allergic to the test sample. 3. Patients with heart, liver, kidney and other major organ complications, or with other serious diseases, mental patients, taking glucocorticoids or other drugs that affect blood sugar. 4. Diabetic ketosis, acidosis and infection in the last 3 months. 5. Short-term use of items related to the function of the test, affecting the judge of the result. 6. Those who do not meet the inclusion criteria, do not take the test sample as prescribed, or have incomplete data that affect the observation results. (1) secondary obesity (hypothalamic obesity, hypercortisolism); (2) Muscular; (3) hypogonadal obesity; (4) drug-induced obesity; (5) pregnancy and lactation; (6) serious diseases (liver and kidney insufficiency, coronary heart disease and tumor, etc.); (7) hypothyroidism obesity.

Design outcomes

Primary

Measure	Time frame
Blood glucose drop;Hemoglobin A1c decline;Fasting blood-glucose;The decrease of glycosylated serum protein;Blood sugar two hours after a meal;Insulin;Blue acid;TNF-a;Hs-CRP;MCP-1;IL-1;IL-6;Adiponectin;G6Pase;GLP-1;LEP;GHRP-Ghrelin;NPY;TG;TC;LDL-G;HDL-C;	—

Secondary

Measure	Time frame
Dietary status;Drug usage;Activity;Blood routine examination;Routine urine test;Stool for routine;Liver function;Renal function;	—

Countries

China

Contacts

Public ContactGao Weidong

Lianshui People's Hospital, Kangda College, Nanjing Medical University

yangligang2012@163.com+86 138 1398 1531

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026